Novel acetyl-CoA Carboxylase (ACC) Inhibitors and their use in Diabetes, Obesity and Metabolic Syndrome
申请人:Keyes Robert F.
公开号:US20090048298A1
公开(公告)日:2009-02-19
The present invention relates to compounds of formula (I)
which inhibit acetyl-CoA carboxylase (ACC) and are useful for the prevention or treatment of metabolic syndrome, type II diabetes, obesity, atherosclerosis and cardiovascular diseases in humans.
Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
申请人:Abbott Laboratories
公开号:US08207350B2
公开(公告)日:2012-06-26
The present invention relates to compounds of formula (I)
which inhibit acetyl-CoA carboxylase (ACC) and are useful for the prevention or treatment of metabolic syndrome, type II diabetes, obesity, atherosclerosis and cardiovascular diseases in humans.
The present disclosure addresses elastomeric adhesives and elastomers that include a modified amine. The modified amine can be the reaction product of an amine with a Michael acceptor. The amine can be represented by H
2
N—Ar—R
1
—NH
2
, wherein Ar is an arylene and R1 is selected from an alkylene and alkenylene. The Michael acceptor can be selected from a variety of compounds including maleates, fumarates, acrylates, and others.